Rabindranath Tripathy

745 total citations
18 papers, 610 citations indexed

About

Rabindranath Tripathy is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rabindranath Tripathy has authored 18 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Rabindranath Tripathy's work include Calpain Protease Function and Regulation (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Rabindranath Tripathy is often cited by papers focused on Calpain Protease Function and Regulation (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Rabindranath Tripathy collaborates with scholars based in United States and India. Rabindranath Tripathy's co-authors include R. W. FRANCK, John P. Mallamo, Kay D. Onan, Thelma S. Angeles, Patrick J. Carroll, Mark S. Albom, Edward R. Thornton, Shi Yang, Mark A. Ator and J. B. Singh and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Industrial & Engineering Chemistry Research.

In The Last Decade

Rabindranath Tripathy

17 papers receiving 551 citations

Peers

Rabindranath Tripathy
Yinghong Gao United States
Darin E. Jones United States
James W. Cessac United States
Jerry R. Brooks United States
María J. Comin Argentina
Andrei W. Konradi United States
Helen Browne United Kingdom
Ron Bihovsky United States
Yinghong Gao United States
Rabindranath Tripathy
Citations per year, relative to Rabindranath Tripathy Rabindranath Tripathy (= 1×) peers Yinghong Gao

Countries citing papers authored by Rabindranath Tripathy

Since Specialization
Citations

This map shows the geographic impact of Rabindranath Tripathy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabindranath Tripathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabindranath Tripathy more than expected).

Fields of papers citing papers by Rabindranath Tripathy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabindranath Tripathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabindranath Tripathy. The network helps show where Rabindranath Tripathy may publish in the future.

Co-authorship network of co-authors of Rabindranath Tripathy

This figure shows the co-authorship network connecting the top 25 collaborators of Rabindranath Tripathy. A scholar is included among the top collaborators of Rabindranath Tripathy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabindranath Tripathy. Rabindranath Tripathy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Tripathy, Rabindranath, Robert J. McHugh, Arup K. Ghose, et al.. (2011). Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: Control of selectivity by a benzyloxy group. Bioorganic & Medicinal Chemistry Letters. 21(24). 7261–7264. 27 indexed citations
3.
Albom, Mark S., Thelma S. Angeles, Jean Husten, et al.. (2010). Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(1). 164–167. 22 indexed citations
4.
Ott, Gregory R., Rabindranath Tripathy, Mangeng Cheng, et al.. (2010). Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity. ACS Medicinal Chemistry Letters. 1(9). 493–498. 38 indexed citations
5.
Tripathy, Rabindranath, Thelma S. Angeles, Shi Yang, & John P. Mallamo. (2008). TrkA kinase inhibitors from a library of modified and isosteric Staurosporine aglycone. Bioorganic & Medicinal Chemistry Letters. 18(12). 3551–3555. 18 indexed citations
6.
Tripathy, Rabindranath, Arup K. Ghose, J. B. Singh, et al.. (2007). 1,2,3‐Thiadiazole Substituted Pyrazolones as Potent KDR/VEGFR‐2 Kinase Inhibitors.. ChemInform. 38(30). 3 indexed citations
7.
Tripathy, Rabindranath, Mohamed Iqbal, J. B. Singh, et al.. (2006). Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 16(8). 2158–2162. 88 indexed citations
8.
Tripathy, Rabindranath, Arup K. Ghose, J. B. Singh, et al.. (2006). 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(6). 1793–1798. 79 indexed citations
9.
Tripathy, Rabindranath, et al.. (2002). Construction of a kinase inhibitor library via parallel synthesis. Tetrahedron Letters. 43(2). 217–220. 4 indexed citations
10.
Tripathy, Rabindranath, Mark A. Ator, & John P. Mallamo. (2000). Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents. Bioorganic & Medicinal Chemistry Letters. 10(20). 2315–2319. 17 indexed citations
11.
Tripathy, Rabindranath, et al.. (1998). P2-proline-derived inhibitors of calpain I. Bioorganic & Medicinal Chemistry Letters. 8(19). 2647–2652. 10 indexed citations
12.
Chatterjee, Sankar, Derek Dunn, Ming Tao, et al.. (1998). d-Amino Acid Containing, High-Affinity Inhibitors of Recombinant Human Calpain I. Journal of Medicinal Chemistry. 41(15). 2663–2666. 30 indexed citations
13.
Chatterjee, Sankar, Mark A. Ator, Donna Bozyczko‐Coyne, et al.. (1997). Synthesis and Biological Activity of a Series of Potent Fluoromethyl Ketone Inhibitors of Recombinant Human Calpain I. Journal of Medicinal Chemistry. 40(23). 3820–3828. 39 indexed citations
14.
Iqbal, Mohamed, Manoja Kumar Das, Sankar Chatterjee, et al.. (1997). Subsite requirements for peptide aldehyde inhibitors of human calpain I. Bioorganic & Medicinal Chemistry Letters. 7(5). 539–544. 37 indexed citations
15.
Tripathy, Rabindranath, Patrick J. Carroll, & Edward R. Thornton. (1991). Diene-dienophile hydrogen-bonding control of Diels-Alder reactions with dienes bearing a remote stereogenic center. Amplification of the receptor nature of dienes by conformational tuning leading to high diastereofacial discrimination. Journal of the American Chemical Society. 113(20). 7630–7640. 33 indexed citations
16.
Tripathy, Rabindranath, Patrick J. Carroll, & Edward R. Thornton. (1990). Asymmetric Diels-Alder reactions with chiral dienes. Control of facial selectivity through hydrogen bonding. Journal of the American Chemical Society. 112(18). 6743–6744. 33 indexed citations
17.
FRANCK, R. W., et al.. (1990). Effect of allylic substituents on the face selectivity of Diels-Alder reactions of semicyclic dienes. Journal of the American Chemical Society. 112(23). 8472–8478. 48 indexed citations
18.
Tripathy, Rabindranath, R. W. FRANCK, & Kay D. Onan. (1988). Diels-Alder reaction of dienes having stereogenic allylic substituents: control of diastereoface selectivity by the dienophile. Journal of the American Chemical Society. 110(10). 3257–3262. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026